{"id":14687,"date":"2023-07-03T13:04:07","date_gmt":"2023-07-03T11:04:07","guid":{"rendered":"https:\/\/eisai.ch\/demence-dalzheimer\/"},"modified":"2025-11-13T16:21:29","modified_gmt":"2025-11-13T15:21:29","slug":"demence-dalzheimer","status":"publish","type":"page","link":"https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/demence-dalzheimer\/","title":{"rendered":"D\u00e9mence d’Alzheimer"},"content":{"rendered":"

\"Eisai<\/span><\/div><\/div><\/div>
<\/div>

Elle porte le nom du neurologue allemand Alois Alzheimer, qui a \u00e9t\u00e9 le premier \u00e0 d\u00e9crire les sympt\u00f4mes et les modifications c\u00e9r\u00e9brales typiques en 1906. La maladie se caract\u00e9rise par la perte lente et progressive de cellules nerveuses et de contacts entre les cellules nerveuses. Des d\u00e9p\u00f4ts de prot\u00e9ines (plaques amylo\u00efdes et enchev\u00eatrements de tau) sont d\u00e9celables dans le cerveau des malades.
\nLes troubles de la m\u00e9moire et de l’orientation, les troubles de la capacit\u00e9 de r\u00e9flexion et de jugement ainsi que les modifications de la personnalit\u00e9 font partie du tableau clinique. Ces troubles peuvent \u00eatre plus ou moins prononc\u00e9s chez les personnes concern\u00e9es et rendent de plus en plus difficile le d\u00e9roulement normal de la vie quotidienne. Le premier interlocuteur en cas de troubles est g\u00e9n\u00e9ralement le m\u00e9decin de famille. En cas de suspicion de d\u00e9mence, on collabore souvent avec des m\u00e9decins sp\u00e9cialistes (neurologie, psychiatrie, g\u00e9riatrie). <\/p>\n

Eisai dispose d’une longue exp\u00e9rience dans le domaine de la d\u00e9mence d’Alzheimer et travaille au d\u00e9veloppement de nouveaux m\u00e9dicaments pour le traitement de la maladie.<\/p>\n

Vous trouverez des informations sur la d\u00e9mence d’Alzheimer \u00e0 l’intention des patients et de leurs proches, par exemple via les liens suivants :<\/strong><\/p>\n

Alzheimer Suisse<\/a><\/p>\n

Aide en cas de maladie d’Alzheimer – Croix-Rouge suisse<\/a><\/p>\n<\/div>

<\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>

Autres domaines th\u00e9rapeutiques<\/h2><\/div>
<\/div><\/div><\/div>

\u00c9pilepsie<\/a><\/h4><\/div>

L’\u00e9pilepsie est une maladie chronique du cerveau qui touche des personnes de tous \u00e2ges dans le monde entier. C’est l’une des maladies neurologiques les plus courantes, qui toucherait 50 millions de personnes dans le monde1<\/sup>.<\/p>\n<\/div>

<\/div><\/div>\n

1. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy [consult\u00e9 le 04.12.2023]<\/a>.<\/p>\n<\/div>

<\/div>
En savoir plus<\/span><\/a><\/div>
<\/div><\/div><\/div>\n<\/div><\/div>
<\/div>
<\/div><\/div>

Professionnels<\/p>\n<\/div>

<\/div><\/div>

Vous \u00eates un professionnel et vous cherchez des informations sur nos pr\u00e9parations ?<\/h2><\/div>
<\/div>

Pour toute information sur nos pr\u00e9parations, veuillez nous contacter directement, consulter le site de l’Institut suisse des produits th\u00e9rapeutiques Swissmedic<\/a> ou notre plate-forme d’information pour les professionnels \u00e0 l’adresse www.eisaipro.eu\/en-ch.<\/a><\/p>\n<\/div>\n

Contact<\/span><\/a><\/div>\n<\/div><\/div><\/div><\/div>\n
<\/span><\/a><\/span>
\"Eisai<\/span><\/div>

Recherche et d\u00e9veloppement<\/p>\n<\/div>

<\/div><\/div>\n

Recherche et d\u00e9veloppement<\/h2><\/div>
<\/div>

Eisai a deux domaines strat\u00e9giques cl\u00e9s : Les maladies neurologiques et le cancer (oncologie).<\/p>\n<\/div>

<\/div>
en savoir plus<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>\n
<\/span><\/a><\/span>
\"Eisai<\/span><\/div>

Transparence<\/p>\n<\/div>

<\/div><\/div>\n

Responsabilit\u00e9 et transparence<\/h2><\/div>
<\/div>

Eisai a d\u00e9fini la „compliance“ – le strict respect des normes l\u00e9gales et \u00e9thiques – comme base de ses activit\u00e9s d’entreprise. Eisai est membre de l’association \u00e9conomique suisse „Scienceindustries“ et a sign\u00e9 le code de coop\u00e9ration pharmaceutique.<\/p>\n<\/div>

<\/div>
en savoir plus<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>\n<\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":14724,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-14687","page","type-page","status-publish","hentry"],"yoast_head":"\nD\u00e9mence d'Alzheimer — Eisai Pharma AG<\/title>\n<meta name=\"description\" content=\"Eisai dispose d'une longue exp\u00e9rience dans le domaine de la d\u00e9mence d'Alzheimer & travaille au d\u00e9veloppement de nouveaux traitements.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/demence-dalzheimer\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"D\u00e9mence d'Alzheimer — Eisai Pharma AG\" \/>\n<meta property=\"og:description\" content=\"Eisai dispose d'une longue exp\u00e9rience dans le domaine de la d\u00e9mence d'Alzheimer & travaille au d\u00e9veloppement de nouveaux traitements.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/demence-dalzheimer\/\" \/>\n<meta property=\"og:site_name\" content=\"Eisai Pharma AG\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-13T15:21:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eisai.ch\/wp-content\/uploads\/2019\/09\/iStock-643686670-1024x683.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/domaines-therapeutiques\\\/demence-dalzheimer\\\/\",\"url\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/domaines-therapeutiques\\\/demence-dalzheimer\\\/\",\"name\":\"D\u00e9mence d'Alzheimer — Eisai Pharma AG\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/#website\"},\"datePublished\":\"2023-07-03T11:04:07+00:00\",\"dateModified\":\"2025-11-13T15:21:29+00:00\",\"description\":\"Eisai dispose d'une longue exp\u00e9rience dans le domaine de la d\u00e9mence d'Alzheimer & travaille au d\u00e9veloppement de nouveaux traitements.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/domaines-therapeutiques\\\/demence-dalzheimer\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eisai.ch\\\/fr\\\/domaines-therapeutiques\\\/demence-dalzheimer\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/domaines-therapeutiques\\\/demence-dalzheimer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/startseite\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Domaines th\u00e9rapeutiques\",\"item\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/domaines-therapeutiques\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"D\u00e9mence d’Alzheimer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/\",\"name\":\"Eisai Schweiz\",\"description\":\"Eisai in der Schweiz\",\"publisher\":{\"@id\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/#organization\"},\"alternateName\":\"Eisai Pharma AG\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/#organization\",\"name\":\"Eisai Pharma AG\",\"alternateName\":\"Eisai Suisse\",\"url\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/eisai.ch.dedi3391.your-server.de.dedi3391.your-server.de\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/eisai-logo-big-1.png\",\"contentUrl\":\"http:\\\/\\\/eisai.ch.dedi3391.your-server.de.dedi3391.your-server.de\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/eisai-logo-big-1.png\",\"width\":334,\"height\":200,\"caption\":\"Eisai Pharma AG\"},\"image\":{\"@id\":\"https:\\\/\\\/eisai.ch\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"D\u00e9mence d'Alzheimer — Eisai Pharma AG","description":"Eisai dispose d'une longue exp\u00e9rience dans le domaine de la d\u00e9mence d'Alzheimer & travaille au d\u00e9veloppement de nouveaux traitements.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/demence-dalzheimer\/","og_locale":"fr_FR","og_type":"article","og_title":"D\u00e9mence d'Alzheimer — Eisai Pharma AG","og_description":"Eisai dispose d'une longue exp\u00e9rience dans le domaine de la d\u00e9mence d'Alzheimer & travaille au d\u00e9veloppement de nouveaux traitements.","og_url":"https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/demence-dalzheimer\/","og_site_name":"Eisai Pharma AG","article_modified_time":"2025-11-13T15:21:29+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/eisai.ch\/wp-content\/uploads\/2019\/09\/iStock-643686670-1024x683.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/demence-dalzheimer\/","url":"https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/demence-dalzheimer\/","name":"D\u00e9mence d'Alzheimer — Eisai Pharma AG","isPartOf":{"@id":"https:\/\/eisai.ch\/fr\/#website"},"datePublished":"2023-07-03T11:04:07+00:00","dateModified":"2025-11-13T15:21:29+00:00","description":"Eisai dispose d'une longue exp\u00e9rience dans le domaine de la d\u00e9mence d'Alzheimer & travaille au d\u00e9veloppement de nouveaux traitements.","breadcrumb":{"@id":"https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/demence-dalzheimer\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/demence-dalzheimer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/demence-dalzheimer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eisai.ch\/fr\/startseite\/"},{"@type":"ListItem","position":2,"name":"Domaines th\u00e9rapeutiques","item":"https:\/\/eisai.ch\/fr\/domaines-therapeutiques\/"},{"@type":"ListItem","position":3,"name":"D\u00e9mence d’Alzheimer"}]},{"@type":"WebSite","@id":"https:\/\/eisai.ch\/fr\/#website","url":"https:\/\/eisai.ch\/fr\/","name":"Eisai Schweiz","description":"Eisai in der Schweiz","publisher":{"@id":"https:\/\/eisai.ch\/fr\/#organization"},"alternateName":"Eisai Pharma AG","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eisai.ch\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/eisai.ch\/fr\/#organization","name":"Eisai Pharma AG","alternateName":"Eisai Suisse","url":"https:\/\/eisai.ch\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/eisai.ch\/fr\/#\/schema\/logo\/image\/","url":"http:\/\/eisai.ch.dedi3391.your-server.de.dedi3391.your-server.de\/wp-content\/uploads\/2019\/12\/eisai-logo-big-1.png","contentUrl":"http:\/\/eisai.ch.dedi3391.your-server.de.dedi3391.your-server.de\/wp-content\/uploads\/2019\/12\/eisai-logo-big-1.png","width":334,"height":200,"caption":"Eisai Pharma AG"},"image":{"@id":"https:\/\/eisai.ch\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/eisai.ch\/fr\/wp-json\/wp\/v2\/pages\/14687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eisai.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/eisai.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/eisai.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eisai.ch\/fr\/wp-json\/wp\/v2\/comments?post=14687"}],"version-history":[{"count":14,"href":"https:\/\/eisai.ch\/fr\/wp-json\/wp\/v2\/pages\/14687\/revisions"}],"predecessor-version":[{"id":15427,"href":"https:\/\/eisai.ch\/fr\/wp-json\/wp\/v2\/pages\/14687\/revisions\/15427"}],"up":[{"embeddable":true,"href":"https:\/\/eisai.ch\/fr\/wp-json\/wp\/v2\/pages\/14724"}],"wp:attachment":[{"href":"https:\/\/eisai.ch\/fr\/wp-json\/wp\/v2\/media?parent=14687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}